China's rapid rise creates 'heightened risks' for pharma: PwC

PwC analysts have warned the speedy evolution of the Chinese biotech sector is creating “heightened risks related to IP security, regulatory compliance and strategic alignment.”

Jun 18, 2025 - 11:00
 0
China's rapid rise creates 'heightened risks' for pharma: PwC
PwC analysts have warned the speedy evolution of the Chinese biotech sector is creating “heightened risks related to IP security, regulatory compliance and strategic alignment.”